About
Technology
Issues
FAQ
Links
Official Page
Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.